You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment

Article metrics

Article menu

Download PDFPDF

Research Article
Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment

 

Online download statistics by month:

Online download statistics by month: December 2019 to July 2025

AbstractFullPdf
Dec 2019220
Jan 202013132
Feb 202029293
Mar 202034343
Apr 202036367
May 2020343412
Jun 202033335
Jul 202023234
Aug 202021215
Sep 202041412
Oct 202044447
Nov 2020585914
Dec 202037376
Jan 2021666616
Feb 202148487
Mar 202153538
Apr 2021656515
May 202195955
Jun 2021747417
Jul 202138383
Aug 202129295
Sep 2021515115
Oct 2021525214
Nov 2021494913
Dec 2021454713
Jan 2022424311
Feb 2022282814
Mar 202231317
Apr 2022333311
May 2022525418
Jun 2022434514
Jul 2022768227
Aug 2022656814
Sep 2022818117
Oct 2022707113
Nov 20226811323
Dec 2022424210
Jan 2023606310
Feb 202363636
Mar 2023636313
Apr 2023394110
May 202352528
Jun 202350506
Jul 2023545412
Aug 202351516
Sep 202393939
Oct 202313213217
Nov 2023981007
Dec 202318218814
Jan 2024555611
Feb 2024909017
Mar 2024757528
Apr 2024677115
May 2024393929
Jun 2024464718
Jul 2024767922
Aug 20245857200
Sep 2024464714
Oct 2024545423
Nov 2024788015
Dec 202411911917
Jan 2025989829
Feb 202569709
Mar 2025646417
Apr 2025808012
May 2025383822
Jun 2025464717
Jul 2025110
Total383739261013